Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to journals
Academic JournalOpen Access

Biomedicines

2 Papers Indexed in Blossom

Published Papers

Open Accessmeta

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials

This meta-analysis (n=92) highlights the large, and positive effects of psilocybin-assisted psychotherapy for depression and anxiety related to life-threatening diseases (end-of-life anxiety), it also recommends using it in the first-line (considering the safety profile).

Published
September 1, 2020
Journal
Biomedicines
Authors
Vargas, A. S., Luís, Â., Barroso, M., Gallardo, E., Pereira, L.
Open Accessindividual

Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience

In healthy adults (n = 55) greater cortical thickness of the rostral anterior cingulate, but not the caudal or posterior cingulate, predicted higher scores on the emotional subscales of the 5D-ASC after controlling for age and sex. This finding implies that individual differences in brain structure help explain variability in emotional responses to psilocybin, extending the traditional set-and-setting account.

Published
February 18, 2020
Journal
Biomedicines
Authors
Lewis, C. R., Preller, K. H., Braden, B. B., Riecken, C., Vollenweider, F. X.

Quick Facts

Papers Indexed
2
h-Index
85
Open Access
Yes
Publisher
MDPI
Country
Switzerland
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.